Media Summary: We talked with Durhane Wong-Rieger on what CORD is doing to get legislation passed that will finally give Canada Emil Kakkis, MD, President and Founder of Ultragenyx Pharmaceutical Inc., explains that while Over 6000 different rare diseases identified to date affect 3.5% – 5.9% of the worldwide population. They have a big impact not ...

The Orphan Drug Regulatory Framework - Detailed Analysis & Overview

We talked with Durhane Wong-Rieger on what CORD is doing to get legislation passed that will finally give Canada Emil Kakkis, MD, President and Founder of Ultragenyx Pharmaceutical Inc., explains that while Over 6000 different rare diseases identified to date affect 3.5% – 5.9% of the worldwide population. They have a big impact not ... Welcome to the PharmaCamp with Neha. This is a small initiative from my side to share knowledge about the Amy Comstock Rick, JD, President and Chief Executive Officer of the Food and Just like that, this potentially life-altering treatment becomes

The next piece that I want to talk about was Within the European Joint Programme for Rare diseases, EATRIS and the EMA's Today, there are many misconceptions about In the United States, the median price for MDUK Oxford Neuromuscular Centre Seminar Series 01/21/25 Walking Your

Photo Gallery

The Orphan Drug Regulatory Framework
The Orphan Drug Act is Just One Factor in Orphan Drug Development
What are Orphan Medicines? - Video explainer
Orphan Drugs part 4: Fixing the System
Orphan Drug Development | Episode  01- What is Orphan Drug? | Rare Disease | Drug Regulatory Affairs
Paul Melmeyer | Drug Regulation & the Orphan Drug Act
Orphan Drug Innovation Needs and Priorities: CeBIL Symposium 2021
Amy Comstock Rick, JD | Drug Regulation & the Orphan Drug Act
The Orphan Drug Machine
Danielle Friend, Ph.D | Drug Regulation & the Orphan Drug Act
How to apply and benefit from an Orphan Drug Designation
Orphan Drug Development | Episode  02- What is Orphan Drug Designation?  | Drug Regulatory Affairs
View Detailed Profile
The Orphan Drug Regulatory Framework

The Orphan Drug Regulatory Framework

We talked with Durhane Wong-Rieger on what CORD is doing to get legislation passed that will finally give Canada

The Orphan Drug Act is Just One Factor in Orphan Drug Development

The Orphan Drug Act is Just One Factor in Orphan Drug Development

Emil Kakkis, MD, President and Founder of Ultragenyx Pharmaceutical Inc., explains that while

What are Orphan Medicines? - Video explainer

What are Orphan Medicines? - Video explainer

Over 6000 different rare diseases identified to date affect 3.5% – 5.9% of the worldwide population. They have a big impact not ...

Orphan Drugs part 4: Fixing the System

Orphan Drugs part 4: Fixing the System

Drug companies love

Orphan Drug Development | Episode  01- What is Orphan Drug? | Rare Disease | Drug Regulatory Affairs

Orphan Drug Development | Episode 01- What is Orphan Drug? | Rare Disease | Drug Regulatory Affairs

Welcome to the PharmaCamp with Neha. This is a small initiative from my side to share knowledge about the

Paul Melmeyer | Drug Regulation & the Orphan Drug Act

Paul Melmeyer | Drug Regulation & the Orphan Drug Act

Paul Melmeyer, Director of Federal

Orphan Drug Innovation Needs and Priorities: CeBIL Symposium 2021

Orphan Drug Innovation Needs and Priorities: CeBIL Symposium 2021

In response,

Amy Comstock Rick, JD | Drug Regulation & the Orphan Drug Act

Amy Comstock Rick, JD | Drug Regulation & the Orphan Drug Act

Amy Comstock Rick, JD, President and Chief Executive Officer of the Food and

The Orphan Drug Machine

The Orphan Drug Machine

Just like that, this potentially life-altering treatment becomes

Danielle Friend, Ph.D | Drug Regulation & the Orphan Drug Act

Danielle Friend, Ph.D | Drug Regulation & the Orphan Drug Act

The next piece that I want to talk about was

How to apply and benefit from an Orphan Drug Designation

How to apply and benefit from an Orphan Drug Designation

Within the European Joint Programme for Rare diseases, EATRIS and the EMA's

Orphan Drug Development | Episode  02- What is Orphan Drug Designation?  | Drug Regulatory Affairs

Orphan Drug Development | Episode 02- What is Orphan Drug Designation? | Drug Regulatory Affairs

Welcome to the PharmaCamp with Neha. This is a small initiative from my side to share knowledge about the

What Is "Orphan Drug Status?"

What Is "Orphan Drug Status?"

Find out what "

5 Myths About Orphan Drugs and the Orphan Drug Act

5 Myths About Orphan Drugs and the Orphan Drug Act

Today, there are many misconceptions about

Orphan Drugs: An Introduction

Orphan Drugs: An Introduction

In the United States, the median price for

Gaming the System: Orphan Drugs Part 3

Gaming the System: Orphan Drugs Part 3

This week, we continue our series on

Beyond the Initial Cure: Expanding the Horizons of Orphan Drug Indications

Beyond the Initial Cure: Expanding the Horizons of Orphan Drug Indications

Stanford Biodesign

Aaron Friedman's Work on Rare Diseases

Aaron Friedman's Work on Rare Diseases

Aaron Friedman is a

Orphan Drug Regulatory Affairs 101: Walking Your Orphan Through The FDA (Part 1)

Orphan Drug Regulatory Affairs 101: Walking Your Orphan Through The FDA (Part 1)

MDUK Oxford Neuromuscular Centre Seminar Series 01/21/25 Walking Your

Meet the Authors: Orphan Drug Development for Rare Diseases

Meet the Authors: Orphan Drug Development for Rare Diseases

The authors of RAPS'